janumet xr 50 mg/1000 mg comprimés pelliculés
msd merck sharp & dohme ag - metformini hydrochloridum, sitagliptinum - comprimés pelliculés - metformini hydrochloridum 1000 mg, sitagliptini phosphas monohydricus 64.25 mg corresp. sitagliptinum 50 mg, povidonum k 29-32, hypromellosum, silica colloidalis anhydrica, natrii stearylis fumaras corresp. natrium 1.78 mg, e 310, macrogolum 3350, kaolinum leve, Überzug: hypromellosum, hydroxypropylcellulosum, e 171, e 172 (flavum), e 132, cera carnauba, pro compresso obducto. - antidiabétique oral utilisé - synthetika
janumet xr 100 mg/1000 mg comprimés pelliculés
msd merck sharp & dohme ag - metformini hydrochloridum, sitagliptinum - comprimés pelliculés - metformini hydrochloridum 1000 mg, sitagliptini phosphas monohydricus 128.5 mg corresp. sitagliptinum 100 mg, povidonum k 29-32, hypromellosum, silica colloidalis anhydrica, natrii stearylis fumaras corresp. natrium 1.77 mg, e 310, macrogolum 3350, kaolinum leve, Überzug: hypromellosum, hydroxypropylcellulosum, e 171, e 132, cera carnauba, pro compresso obducto. - antidiabétique oral utilisé - synthetika
sitagliptin metformin axapharm 50 mg/500 mg comprimés pelliculés
axapharm ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 500.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 0.7 mg. - antidiabétique oral utilisé - synthetika
sitagliptin metformin axapharm 50 mg/850 mg comprimés pelliculés
axapharm ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 850.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.1 mg. - antidiabétique oral utilisé - synthetika
sitagliptin metformin axapharm 50 mg/1000 mg comprimés pelliculés
axapharm ag - sitagliptinum, metformini hydrochloridum - comprimés pelliculés - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 1000.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.3 mg. - antidiabétique oral utilisé - synthetika
galvus
novartis europharm limited - vildagliptine - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptine - diabète sucré, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).
xiliarx
novartis europharm limited - vildagliptine - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).
vildagliptine/metformine teva 50 mg/1000 mg, comprimé pelliculé
teva bv - metformine - comprimé - 780 mg - composition pour un comprimé > metformine : 780 mg . sous forme de : chlorhydrate de metformine 1000 mg > vildagliptine : 50 mg - médicaments utilisés en cas de diabète, associations d’hypoglycémiants oraux
vildagliptine/metformine sandoz 50 mg/850 mg, comprimé pelliculé
sandoz - metformine - comprimé - 660 mg - composition pour un comprimé > metformine : 660 mg . sous forme de : chlorhydrate de metformine 850 mg > vildagliptine : 50 mg - médicaments utilisés en cas de diabète, associations d’hypoglycémiants oraux